Abstract:<p>Bladder cancer is a menace to global health worldwide due to its high recurrence rate and its progression to invasive muscular complications. Cell adhesion molecules play an intricate role in cancer migration, growth, and invasion. Therefore, through bioinformatics analysis, it was found that the higher cerebral endothelial cell adhesion molecule (CERCAM) predicted lower chance in bladder cancer patient survival; subsequently, in vitro and in vivo investigations were performed to evaluate the specific effects of CERCAM on bladder cancer cell phenotypes and tumor growth in mice model. The PCR-based analysis revealed an aberrant upregulation of CERCAM in bladder carcinoma tissues and cells when compared with normal controls. In vitro, functional experiments such as MTT, EdU, and Transwell assays showed that CERCAM overexpression markedly enhanced bladder cancer cell viability, DNA synthesis, and cell invasion. In contrast, CERCAM silencing suppressed bladder cancer cell viability, DNA synthesis, and cell invasion. CERCAM overexpression significantly increased PCNA, Vimentin, Twist, and N-cadherin proteins but decreased E-cadherin and cleaved-caspase3, whereas CERCAM silencing exerted opposite effects on these markers. In vivo, subcutaneous implant model experiments in nude mice showed that CERCAM silencing suppressed the growth of subcutaneously implanted tumors. CERCAM altered the phosphorylation process of AKT. The PI3K inhibitor LY294002 treatment manifested similar effects as CERCAM silencing on bladder cancer cell behaviors and partially impaired the promotive functions of CERCAM overexpression upon the capacity of bladder cancer cells to proliferate and invade. When taken together, the cell adhesion molecule CERCAM is overexpressed in bladder cancer tissues. In vitro, CERCAM overexpression significantly promoted bladder cancer cell viability, DNA synthesis, and cell invasion and alters the cleaved-caspase3, E-cadherin, and N-cadherin expression pattern; in vivo, CERCAM silencing suppressed tumor growth in nude mice. The PI3K/AKT signaling is suspected of interfering participate in the functions of CERCAM in bladder carcinoma.</p>

CCL21/CCR7 Enhances the Proliferation, Migration, and Invasion of Human Bladder Cancer T24 Cells.

CCL21/CCR7 Interaction Promotes Cellular Migration and Invasion Via Modulation of the MEK/ERK1/2 Signaling Pathway and Correlates with Lymphatic Metastatic Spread and Poor Prognosis in Urinary Bladder Cancer.

CXCL5 knockdown expression inhibits human bladder cancer T24 cells proliferation and migration.

RNA Interference-Mediated Vascular Endothelial Growth Factor-C Reduction Suppresses Malignant Progression and Enhances Mitomycin C Sensitivity of Bladder Cancer T24 Cells

CC Chemokine Ligand 21 Enhances the Immunogenicity of the Breast Cancer Cell Line MCF-7 Upon Assistance of TLR2.

Abstract 6809: Tumor-associated macrophages promote bladder cancer cell migration and invasion through activation of CCL20-CCR6 axis

[Role of CCL21/CCR7 in Invasion of Colorectal Carcinoma Cell Line SW480].

CCL18 Enhances Migration, Invasion and EMT by Binding CCR8 in Bladder Cancer Cells

Knockdown of CXCL5 Inhibits the Invasion, Metastasis and Stemness of Bladder Cancer Lung Metastatic Cells by Downregulating CD44

microRNA-21 modulates cell proliferation and sensitivity to doxorubicin in bladder cancer cells

CCL17-CCR4 Axis Promotes Metastasis Via ERK/MMP13 Pathway in Bladder Cancer

Role of chemokine receptor CXCR7 in bladder cancer progression.

Cxcl5/Cxcr2 Axis Promotes Bladder Cancer Cell Migration And Invasion By Activating Pi3k/Akt-Induced Upregulation Of Mmp2/Mmp9

MiR-1-3p inhibits the proliferation and invasion of bladder cancer cells by suppressing CCL2 expression.

CCL25 Promotes the Migration and Invasion of Non-Small Cell Lung Cancer Cells by Regulating VEGF and MMPs in a CCR9-dependent Manner.

The CCL21/CCR7 Pathway Plays a Key Role in Human Colon Cancer Metastasis Through Regulation of Matrix Metalloproteinase-9

The oncogenic role of the cerebral endothelial cell adhesion molecule (CERCAM) in bladder cancer cells in vitro and in vivo

Connexin 43 enhances invasion capacity of bladder cancer cells through P38/MAPK signaling pathway

CXCR4-mediated Stat3 activation is essential for CXCL12-induced cell invasion in bladder cancer

The Clinical Implications and Molecular Mechanism of CX3CL1 Expression in Urothelial Bladder Cancer

Effect of TRPM7 on the Proliferation and Apoptosis in Bladder Cancer T24 Cells